2026 NPPES data Pharmacotherapy Pharmacist NPI 1609240845 PHARM.D.
Verify on CMS →

ROMAN FAZYLOV, PHARM.D.

Pharmacotherapy Pharmacist in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
324
Medicare Part D claims · 42 beneficiaries · Pharmacotherapy Pharmacist avg: 397
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs

What the federal data shows

ROMAN FAZYLOV, PHARM.D. filed 324 Medicare Part D claims in 2023 as a Pharmacotherapy Pharmacist in NEW YORK, New York, prescribing 84% generic.

324
Part D claims, 2023
84%
generic prescribing

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ROMAN FAZYLOV, PHARM.D.'s Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

324 Top 43% higher than 57% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about ROMAN FAZYLOV, PHARM.D.?

Quality data not reported

NPI registry status

Active

Issued 11/28/2015

NPI 1609240845

Primary specialty

Pharmacotherapy Pharmacist

Mid-sized

5,925 US NPIs in this specialty

Medicare Part D claims

324 18% vs specialty avg

2023 prescription claims

Specialty avg: 397

Specialty distribution in New York

How Pharmacotherapy Pharmacist compares to other specialties among New York providers

New York providers

Pharmacotherapy Pharmacist share within New York

1. Pharmacotherapy Pharmacist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pharmacotherapy Pharmacist share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Pharmacotherapy Pharmacist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pharmacotherapy Pharmacist ABMS/AOA estimate

Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pharmacotherapy Pharmacist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ROMAN FAZYLOV, PHARM.D. appears in the CMS NPPES registry as a Pharmacotherapy Pharmacist provider holding PHARM.D. credentials at 800 2ND AVE, NEW YORK, NY, 10017, with a listed phone of (646) 918-7363. NPI 1609240845 was issued on 11/28/2015. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FAZYLOV most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 324 prescription claims written by this provider, covering 42 Medicare beneficiaries and totaling roughly $81K in drug spend, split 16% brand-name and 84% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pharmacotherapy Pharmacist is a mid-sized specialty nationwide, with 5,925 enrolled providers across 53 states and an average of 397 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

800 2ND AVE
NEW YORK, NY 10017

Provider Details

NPI 1609240845
Specialty Pharmacotherapy Pharmacist
Credentials PHARM.D.
Gender Male
NPI Issued 11/28/2015

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ROMAN FAZYLOV, PHARM.D.. To verify ROMAN FAZYLOV, PHARM.D.'s current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

ROMAN FAZYLOV, PHARM.D. — brand share 16.0%
Specialty average (est.)

16% brand-name claims vs 84% generic, on 324 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

324
Total Claims
$81K
Total Drug Cost
42
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
377
Total Day Supply
10,201
Brand vs Generic
16% brand / 84% generic
Brand Drug Cost
$42K
Generic Drug Cost
$38K

Patient Demographics

Average Patient Age
74.3 years
Avg HCC Risk Score
2.73
Gender Split
33% female / 67% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ROMAN FAZYLOV, PHARM.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Warfarin Sodium
116
Tavaborole
18
Oxiconazole Nitrate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pharmacotherapy Pharmacist Overview

How ROMAN FAZYLOV, PHARM.D. fits within the Pharmacotherapy Pharmacist landscape nationally.

5,925
Pharmacotherapy Pharmacist Providers in US
53
States with Pharmacotherapy Pharmacist
397
Avg Claims per Provider

ROMAN FAZYLOV, PHARM.D.'s 324 claims are below the specialty average of 397.

Nearby Pharmacotherapy Pharmacist Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as FAZYLOV.

Compare Pharmacotherapy Pharmacist nationally: see state-by-state distribution →

Frequently Asked Questions

What is ROMAN FAZYLOV, PHARM.D.'s specialty?
ROMAN FAZYLOV, PHARM.D. specializes in Pharmacotherapy Pharmacist and practices in NEW YORK, New York. Credentials: PHARM.D..
How much does ROMAN FAZYLOV, PHARM.D. prescribe under Medicare Part D?
In 2023, ROMAN FAZYLOV, PHARM.D. wrote 324 Medicare Part D claims totaling $81K in drug costs for 42 beneficiaries.
Where is ROMAN FAZYLOV, PHARM.D. located?
ROMAN FAZYLOV, PHARM.D. is located at 800 2ND AVE, NEW YORK, NY, 10017. Phone: (646) 918-7363.
What is ROMAN FAZYLOV, PHARM.D.'s NPI number?
ROMAN FAZYLOV, PHARM.D.'s National Provider Identifier (NPI) is 1609240845, issued on 11/28/2015.
Does ROMAN FAZYLOV, PHARM.D. prescribe more brand-name or generic drugs?
ROMAN FAZYLOV, PHARM.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $42K in brand drug costs.
How many Pharmacotherapy Pharmacist providers are there in the US?
There are 5,925 Pharmacotherapy Pharmacist providers across 53 states in the US. The average Pharmacotherapy Pharmacist provider writes 397 Medicare Part D claims per year.
What drugs does ROMAN FAZYLOV, PHARM.D. prescribe most often?
Based on 2023 Medicare Part D data, ROMAN FAZYLOV, PHARM.D.'s most frequently prescribed drugs include Warfarin Sodium, Tavaborole, Oxiconazole Nitrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ROMAN FAZYLOV, PHARM.D. accept Medicare?
ROMAN FAZYLOV, PHARM.D. appears in CMS Medicare data with 324 Part D claims and 42 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ROMAN FAZYLOV, PHARM.D.'s credentials?
ROMAN FAZYLOV, PHARM.D.'s NPI is 1609240845 with credentials PHARM.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology